aibioRockwell Medical sets 1-for-10 reverse stock split for July 1, 2026
Tickers RMTI
Rockwell Medical's one-for-ten reverse split takes effect at 12:01 a.m. Eastern Time on July 1, 2026. The certificate was filed June 24, and the company says fractional shares will be paid in cash at the June 30 closing price, adjusted by the company.
Key facts
- Company
- Rockwell Medical, Inc. (NASDAQ: RMTI)
- News type
- Listings
- Primary source
- Rockwell Medical, Inc. 8-K (2026-06-29)
Rockwell Medical, Inc. (Nasdaq: RMTI) said in a Form 8-K filed June 29, 2026 that it filed a certificate of amendment with the Delaware Secretary of State on June 24, 2026 to carry out a one-for-ten reverse stock split of its common stock. The split takes effect at 12:01 a.m. Eastern Time on July 1, 2026. Stockholders approved it at the annual meeting held on June 12, 2026.
Under the amendment, each ten shares of common stock outstanding will be combined automatically into one new share, with no action needed from the company or its holders. The common stock is expected to begin trading on a split-adjusted basis at the open on July 1, 2026, under a new CUSIP number, 774374409, and it will keep the symbol RMTI on the Nasdaq Stock Market. The par value stays at $0.0001 per share.
Fractional shares and equity adjustments
No fractional shares will be issued. Holders who would otherwise receive a fraction will be paid cash, without interest and subject to withholding where applicable. The 8-K says the payment is based on the closing price on the Nasdaq Stock Market on June 30, 2026, as adjusted in good faith by the company for the split ratio. The certificate text refers instead to the closing price on the first business day before the effective time, as modified by the company.
The company says it will also adjust, in line with the terms of each instrument, its equity plans, the conversion price and reserved shares of its Series X Convertible Preferred Stock, and the exercise prices and share numbers of its warrants. The filing does not state the resulting figures for any of those instruments.
What the amendment says about authorized shares
The certificate of amendment states that the total number of shares the company may issue is 172,000,000, of which 170,000,000 are designated common stock and 2,000,000 are designated preferred stock, each with a par value of $0.0001. The amendment amends Section 4.1 of Article IV of a certificate of incorporation first filed on August 30, 2019 and amended on May 12, 2022. The copy in the 8-K is labeled as a form, and it is signed by Mark Strobeck, Ph.D., as president and chief executive officer, dated June 24, 2026.
The 8-K does not give a reason for the split. It does not give the trading price of the stock before or after the split, and it says nothing about the company's listing status beyond continued trading on the Nasdaq Stock Market.
The company's finances
The 10-K filed March 26, 2026 reports a net loss of $5.3 million for 2025, against a net loss of $480,000 for 2024. Cash used in operations was $659,000 in 2025, after cash provided by operations of $4.2 million in 2024. Research and development expense was $0 in 2025 and $19,000 in 2024.
Short-term investments were $14.3 million at the end of 2025, up from $5.9 million at the end of 2024. Cash and cash equivalents were $15.7 million at the end of 2024. The filing does not connect the split to those losses or to the cash position.
The business
Rockwell describes itself as a healthcare company that develops, manufactures, commercializes and distributes hemodialysis products for dialysis providers. The 10-K says it is a supplier of liquid and dry, acid and bicarbonate concentrates for dialysis patients in the United States. It makes hemodialysis concentrates at two facilities, in Michigan and Texas, and dry acid concentrate mixers in Iowa. Rockwell says it concluded manufacturing at a South Carolina facility in the third quarter of 2025 to streamline operations. The company was incorporated in Michigan in 1996 and re-domiciled to Delaware in 2019.